Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.
Also called NCT04050592
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose basic science
- Phase
- Phase 4
- Enrolled
- 150 participants
- Registry
-
NCT04050592
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Finland
- Registry status
- Unknown status
Technical summary
Registry record NCT04050592. Randomized; triple masking; primary purpose basic science. Start 2020-02-19 (actual); primary completion 2022-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life
- Condition
- Menopause
- Condition
- Atherosclerosis
- Condition
- Cardiovascular Diseases
- Condition
- Estrogen Replacement Therapy
- Intervention (Drug)
- Estradiol
- Intervention (Other)
- Placebo
- Lead sponsor
- Hanna Savolainen-Peltonen
- Collaborator
- University of Southern California
Record details
- Record id
cardio:ct-nct04050592- Content hash
25f19598682caada2d679a8e163f75a80a0da861d9c424b115ebdc58721fbf62